Safety and efficacy of stapokibart, an anti-interleukin-4 receptor α monoclonal antibody, in children aged 6–11 years with moderate-to-severe atopic dermatitis: an open-label single-arm phase Ib/IIa trial

Stapokibart shows potential in improving disease outcomes and appears to be well tolerated in children aged 6-11 years with moderate-to-severe AD. Larger controlled studies are needed to confirm long-term benefits.

Authors

Institutions

Publication Details

Journal
British Journal of Dermatology
Published
2025-11-23
DOI
https://doi.org/10.1093/bjd/ljaf455
Citations
2
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
4.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety and efficacy of stapokibart, an anti-interleukin-4 receptor α monoclonal antibody, in children aged 6–11 years with moderate-to-severe atopic dermatitis: an open-label single-arm phase Ib/IIa trial

Zhimiao Lin, Qian Qiufang, Guohong Hu, Yangfeng Ding et al.
2 citations
British Journal of Dermatology
Dermatology and Skin Diseases
4.01
article

Safety and efficacy of stapokibart, an anti-interleukin-4 receptor α monoclonal antibody, in children aged 6–11 years with moderate-to-severe atopic dermatitis: an open-label single-arm phase Ib/IIa trial

Zhimiao Lin, Qian Qiufang, Guohong Hu, Yangfeng Ding, Xu Li, Bin Yang, Zigang Xu, Lin Ma, Mutong Zhao, Liming Wu, Yufeng Xu, Yingmin Jia, Bo Chen, Yanqiu Huang, Hua Wang, Yusong Xu, Wei Zhu, Qin Ran
article en
2 citations

Abstract

Stapokibart shows potential in improving disease outcomes and appears to be well tolerated in children aged 6-11 years with moderate-to-severe AD. Larger controlled studies are needed to confirm long-term benefits.

British Journal of DermatologyVol. 194(4)
Chengdu Medical College (CN), Chengdu Women's and Children's Central Hospital (CN), Jiangxi Chest Hospital (CN), Hunan Children's Hospital (CN), Beijing Children’s Hospital (CN), Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine (CN), Shandong Provincial QianFoShan Hospital (CN), Shanghai Skin Disease Hospital (CN), Shanghai Children's Hospital (CN), Children's Hospital of Chongqing Medical University (CN), Shandong First Medical University (CN), Southern Medical University (CN), Chongqing Medical University (CN)
Openalex Percentile: Top 6%
Dermatology and Skin Diseases
4.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.